How to Evaluate Wholesale Medication Suppliers: The Pharmacy Owner's Due Diligence Playbook

In 2022, a small independent pharmacy in rural Ohio received a shipment of metformin from a secondary wholesale supplier they had found through a cold sales call. The pricing looked excellent — nearly 30% below what their primary distributor quoted. The DSCSA paperwork arrived with the shipment.

Three months later, during a routine state board inspection, the pharmacist learned that the lot number on the metformin did not match any records in the FDA's serialization database. The supplier had gone dark. The pharmacy was left holding $14,000 in unverifiable inventory and facing a formal inquiry.

The lesson is not that secondary wholesalers are dangerous — thousands of legitimate, compliant secondary distributors operate across the US. The lesson is that a low price and a piece of paper are not the same thing as due diligence.

Why Supplier Vetting Is More Critical Now Than Ever

The pharmaceutical supply chain has never been more complex — or more targeted by bad actors. The FDA's MedWatch program logs hundreds of counterfeit and diverted drug reports annually, and the secondary wholesale market, while predominantly legitimate, presents a higher variance in quality than the Big Three primary distributors.

Since DSCSA's enhanced serialization requirements came into full effect, every licensed pharmaceutical distributor must now be an FDA-authorized trading partner and participate in electronic product tracing. But authorization is not the same as vetting. A supplier can be technically authorized and still deliver inconsistent documentation, near-expiry products without disclosure, or service levels that create operational headaches for your pharmacy.

This complexity is one reason many independent pharmacies are turning to verified marketplace platforms as a starting point for finding new suppliers. When a platform like RxWorld.com requires every seller to hold a current pharmacy or wholesale distributor license before they can list inventory, it does not replace your vetting process — but it does meaningfully narrow the pool you are vetting from. You are starting from verified rather than unknown.

The 5-Phase Wholesale Supplier Due Diligence Framework

The following framework is structured in sequence — each phase builds on the last. Do not skip phases based on a supplier's reputation or a colleague's recommendation. Independent verification is the standard.

Phase 1: Licensing Verification (Non-Negotiable)

Before any other evaluation, confirm the supplier's legal standing. This takes approximately 20 minutes and should be performed by you directly — not delegated to the supplier's sales representative.

Phase 2: DSCSA Documentation Audit

Request a sample documentation package before placing your first order. A legitimate supplier will fulfill this request without hesitation. What you receive — and the quality of what you receive — tells you more than any sales pitch.

Request these specific documents:

• A sample Transaction Information (TI) document — verify it includes: product name, strength, dosage form, container size, number of containers, lot number, expiration date, transaction date, and buyer/seller name and address.
• A sample Transaction History (TH) — this must trace the drug back to the original manufacturer, not just the previous owner. A one-step TH ("we bought it from wholesaler X") is insufficient and non-compliant.
• A sample Transaction Statement (TS) — a signed legal attestation that the product was handled lawfully throughout the chain. Unsigned or undated TSs are a red flag.
• Evidence of serialization capability — they should be able to provide GTINs (Global Trade Item Numbers) and serial numbers for unit-level traceability as required under DSCSA.

Phase 3: Operational and Product Quality Assessment

Licensing and documentation are necessary but not sufficient. A supplier can be fully licensed and DSCSA-compliant and still be a poor operational partner. Phase 3 assesses reliability, product quality standards, and the specific risks of the products you intend to purchase.

Questions to ask directly:

• What is your average order fulfillment time from confirmed order to shipping? (Acceptable: same-day to next-business-day; concerning: "it depends" without specifics.)
• How do you handle cold-chain medications? What is your temperature monitoring protocol during transit? Can you provide a sample temperature log from a recent cold-chain shipment?
• What is your policy on near-expiry medications? Do you disclose expiration dates at the time of listing or quoting, or only at shipment? (Disclosure at quoting is the standard; disclosure at shipment is a red flag.)
• What is your returns and discrepancy resolution process? What is the average time to resolve a return credit? Do you have a written policy you can share?
• Who are your primary inventory sources? (They may not share specifics, but a willingness to answer in general terms is a positive signal.)

On platforms like RxWorld.com, sellers are required to include expiration date information in their listings — meaning the green flag of "expiry disclosed upfront" is built into the transaction structure rather than left to the individual seller's discretion.

Phase 4: Reference Verification

A supplier's references are only useful if you actually call them — and ask the right questions. Ask for references from pharmacies that are similar to yours in size, state, and dispensing profile. A reference from a 50-location chain tells you little about how the supplier will treat a single-location independent.

Five questions to ask every reference:

1. How long have you been buying from this supplier, and how regularly?
2. Have you ever had a DSCSA documentation issue with a shipment? How was it resolved?
3. Have you ever received a product that did not match the listing description — wrong lot, wrong expiry, wrong count? What happened?
4. Would you trust this supplier for a high-value medication — say, a specialty generic priced at $800 per unit?
5. Knowing what you know now, would you onboard this supplier again from scratch?

Question 5 is the most revealing. References who pause before answering — or who give a qualified "probably" rather than an immediate "yes" — have told you something important.

Phase 5: First-Order Validation

Every new supplier relationship should begin with a deliberate test order — a low-value, low-risk purchase specifically designed to observe the supplier's actual performance against their promises.

Designing your test order:

• Choose a high-volume generic you know well — a drug you can immediately verify against your own dispensing records and existing inventory.
• Order a small quantity (one to two bottles) — enough to evaluate the process without material financial exposure.
• Time the order: note when you placed it, when you received a confirmation, when it shipped, and when it arrived.
• Inspect the product against the purchase listing: verify lot number, NDC, expiration date, and unit count.
• Collect and review the T3 documents: cross-reference the lot number against the FDA's Drug Enforcement and Registration database.
• Document every step — this first-order file becomes the baseline against which you evaluate every future transaction with this supplier.

The Supplier Scorecard: A Practical Rating System

Use this scorecard to objectively compare multiple suppliers or track a supplier's performance over time. Score each criterion on a 1–5 scale and total the result.

Interpreting your score:

• 4.5 – 5.0: Strong candidate. Proceed with first-order validation.
• 3.5 – 4.4: Acceptable with conditions. Clarify any weak areas before transacting.
• 2.5 – 3.4: Proceed cautiously. Address gaps before purchasing anything beyond low-value generics.
• Below 2.5: Do not purchase. The risk to your pharmacy's compliance and patient safety is not worth the price advantage.

Vetting Isn't One-Time: Ongoing Supplier Monitoring

A supplier who passes your initial due diligence can deteriorate over time. License renewals lapse. Ownership changes. Quality processes slip. Build a monitoring cadence into your pharmacy operations:

• Quarterly: Re-verify your top five suppliers' license status in their home-state database and FDA authorized trading partner list.
• Semi-annually: Conduct a mini performance review: review order accuracy, documentation quality, pricing consistency, and response times over the prior 6 months.
• Annually: Request updated VAWD accreditation certificates (if applicable) and re-run the supplier scorecard.
• Immediately: Re-vet any supplier following a change in ownership, acquisition, or significant personnel change — ask them directly and re-run Phase 1 verification.

Frequently Asked Questions

How long does it take to properly vet a new pharmaceutical wholesale supplier?

A thorough due diligence process — covering all five phases including reference calls — typically takes 3–5 business days. Phase 1 (licensing verification) takes about 20–30 minutes. Phase 2 (documentation audit) depends on how quickly the supplier responds, typically 24–48 hours. Reference calls (Phase 4) require scheduling and can take 2–3 days. Do not compress this process under time pressure — a shortage situation is precisely when bad actors exploit urgency to bypass normal vetting.

Is VAWD accreditation mandatory for a secondary wholesaler?

VAWD accreditation from NABP is not federally mandated, but it is the strongest third-party quality signal available in the secondary wholesale market. Some states require it; others do not. For your purposes, treat VAWD accreditation as a significant positive indicator — it means the supplier has undergone independent audit of their facilities, quality systems, and DSCSA compliance practices. Its absence is not disqualifying, but its presence meaningfully reduces your vetting burden.

What should I do if I discover a supplier I'm already using has a compliance problem?

Stop purchasing from that supplier immediately. Do not return any product — instead, quarantine it separately and contact your state pharmacy board for guidance on how to handle product received from a potentially non-compliant source. Document everything: when you discovered the issue, what the issue was, and every communication with the supplier and regulators. If you have already dispensed product from the suspect lot, consult your pharmacist-in-charge and legal counsel about patient safety obligations.

Can I use a pharmacy B2B marketplace as my primary source for wholesale medications?

A pharmacy B2B marketplace is best used as a supplementary sourcing channel — for spot buying, shortage gap-filling, and accessing overstock inventory at competitive prices — rather than as a replacement for your primary wholesaler relationship. Platforms like RxWorld.com require every seller to be a licensed pharmacy or licensed wholesaler in good standing, which addresses the most common vetting failure point (unlicensed sources). You still need to perform DSCSA documentation review for each transaction, but the pre-verified seller pool materially reduces your exposure to the risks described in this article. Importantly, transactions on RxWorld are intended for specific patient needs or declared public health emergencies — they are not classified as wholesale transactions for general stocking. Factor this into how and when you use the platform.

Disclaimer: This article is for informational purposes only. Regulatory requirements vary by state and are subject to change. Always consult your state pharmacy board and compliance advisors for current requirements.